Julian T. Burn-Callander

No más puestos en curso

Finance

Perfil

Mr. Julian T.
Burn-Callander is Healthcare Specialist at Stifel Nicolaus Europe Ltd.
He joined Oriel Securities Ltd.
before it was acquired by Stifel Nicolaus in February 2015.
Mr. Burn-Callander was previously employed as Head of Life Sciences Equities by Ambrian Partners Ltd., and a Research Analyst by Nomura Code Securities Ltd.

Antiguos cargos conocidos de Julian T. Burn-Callander.

Empresas	Cargo	Fin
Stifel Nicolaus Europe Ltd. Stifel Nicolaus Europe Ltd. Investment Banks/BrokersFinance Stifel Nicolaus Europe Ltd. (SNEL) is a brokerage firm headquartered in London, UK. The firm was founded in 1999 and do-business-as Keefe, Bruyette & Woods Ltd. (KBW). They are a subsidiary of Stifel Europe Holdings Ltd., ultimately owned by Stifel Financial Corp. (NYSE: SF) in the US. SNEL provides Pan-European equity research and sales and trading products for their institutional clients.	Ventas & Marketing	01/12/2016
Oriel Securities Ltd.	Analyst-Equity	-
Nomura Code Securities Ltd.	Analyst-Equity	01/04/2009
Ambrian Partners Ltd.	Director de Investigación - Acciones	09/08/2010

Ver el detalle de la experiencia de Julian T. Burn-Callander.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Julian T. Burn-Callander.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	4
Nomura Code Securities Ltd.	Finance
Ambrian Partners Ltd.	Finance
Oriel Securities Ltd.	Finance
Stifel Nicolaus Europe Ltd. Stifel Nicolaus Europe Ltd. Investment Banks/BrokersFinance Stifel Nicolaus Europe Ltd. (SNEL) is a brokerage firm headquartered in London, UK. The firm was founded in 1999 and do-business-as Keefe, Bruyette & Woods Ltd. (KBW). They are a subsidiary of Stifel Europe Holdings Ltd., ultimately owned by Stifel Financial Corp. (NYSE: SF) in the US. SNEL provides Pan-European equity research and sales and trading products for their institutional clients.	Finance

Ver las conexiones de la empresa